AZN
Price
$82.11
Change
+$1.92 (+2.39%)
Updated
Sep 3 closing price
Capitalization
253.3B
63 days until earnings call
LLY
Price
$737.83
Change
+$2.64 (+0.36%)
Updated
Sep 3 closing price
Capitalization
661.43B
56 days until earnings call
Interact to see
Advertisement

AZN vs LLY

Header iconAZN vs LLY Comparison
Open Charts AZN vs LLYBanner chart's image
AstraZeneca
Price$82.11
Change+$1.92 (+2.39%)
Volume$4.2M
Capitalization253.3B
Eli Lilly & Co
Price$737.83
Change+$2.64 (+0.36%)
Volume$2.22M
Capitalization661.43B
AZN vs LLY Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. LLY commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Buy and LLY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (AZN: $82.11 vs. LLY: $737.83)
Brand notoriety: AZN and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 92% vs. LLY: 47%
Market capitalization -- AZN: $253.3B vs. LLY: $661.43B
AZN [@Pharmaceuticals: Major] is valued at $253.3B. LLY’s [@Pharmaceuticals: Major] market capitalization is $661.43B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $661.43B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileLLY’s FA Score has 2 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • LLY’s FA Score: 2 green, 3 red.
According to our system of comparison, AZN is a better buy in the long-term than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 3 TA indicator(s) are bullish while LLY’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 3 bullish, 5 bearish.
  • LLY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LLY is a better buy in the short-term than AZN.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +2.73% price change this week, while LLY (@Pharmaceuticals: Major) price change was +0.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.55%. For the same industry, the average monthly price growth was +1.88%, and the average quarterly price growth was +9.40%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

LLY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.55% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($661B) has a higher market cap than AZN($253B). LLY has higher P/E ratio than AZN: LLY (48.22) vs AZN (30.93). AZN YTD gains are higher at: 27.995 vs. LLY (-3.854). AZN has less debt than LLY: AZN (32.8B) vs LLY (39.9B).
AZNLLYAZN / LLY
Capitalization253B661B38%
EBITDAN/AN/A-
Gain YTD27.995-3.854-726%
P/E Ratio30.9348.2264%
RevenueN/AN/A-
Total Cash1.41BN/A-
Total Debt32.8B39.9B82%
FUNDAMENTALS RATINGS
AZN vs LLY: Fundamental Ratings
AZN
LLY
OUTLOOK RATING
1..100
2010
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
3425
SMR RATING
1..100
4614
PRICE GROWTH RATING
1..100
5163
P/E GROWTH RATING
1..100
8196
SEASONALITY SCORE
1..100
7546

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZN's Valuation (24) in the Pharmaceuticals Major industry is somewhat better than the same rating for LLY (76). This means that AZN’s stock grew somewhat faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (25) in the Pharmaceuticals Major industry is in the same range as AZN (34). This means that LLY’s stock grew similarly to AZN’s over the last 12 months.

LLY's SMR Rating (14) in the Pharmaceuticals Major industry is in the same range as AZN (46). This means that LLY’s stock grew similarly to AZN’s over the last 12 months.

AZN's Price Growth Rating (51) in the Pharmaceuticals Major industry is in the same range as LLY (63). This means that AZN’s stock grew similarly to LLY’s over the last 12 months.

AZN's P/E Growth Rating (81) in the Pharmaceuticals Major industry is in the same range as LLY (96). This means that AZN’s stock grew similarly to LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNLLY
RSI
ODDS (%)
Bearish Trend 1 day ago
46%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
52%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
69%
Declines
ODDS (%)
Bearish Trend 28 days ago
44%
Bearish Trend 8 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
52%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDX23.611.55
+7.03%
Celldex Therapeutics
TBMC11.67N/A
N/A
Trailblazer Merger Corp
BKHAU10.51N/A
N/A
Black Hawk Acquisition Corp
PBFS13.00-0.05
-0.38%
Pioneer Bancorp
TTC80.53-0.91
-1.12%
Toro Company (The)

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
+2.39%
GSK - AZN
62%
Loosely correlated
+1.03%
NVS - AZN
61%
Loosely correlated
+1.26%
SNY - AZN
49%
Loosely correlated
+0.63%
PFE - AZN
45%
Loosely correlated
-0.76%
LLY - AZN
41%
Loosely correlated
+0.36%
More

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.36%
AZN - LLY
41%
Loosely correlated
+2.39%
BIIB - LLY
37%
Loosely correlated
+1.43%
OGN - LLY
35%
Loosely correlated
+4.35%
MRK - LLY
33%
Poorly correlated
-1.52%
PFE - LLY
31%
Poorly correlated
-0.76%
More